Endoscopic Treatment of Bronchial Carcinoid Tumors

• Sponsor: Centre Hospitalier Universitaire de Saint Etienne (Other)
• Overall Status: Completed
• CT.gov ID: NCT03723499
• Collaborator: (none)
• Enrollment: 70
• Location: 1
• Actual Duration (Months): 265
• Patients Per Site Per Month: 0.3

Study Details

Study Description

Brief Summary

Carcinoid tumors of the lung are considered to be a low-grade malignancy. Surgical resection is considered the standard approach. Recent data has shown that a complete endoscopic treatment could be considered. An endoscopic treatment is can be a alternative to invasive surgery.

Condition or Disease	Intervention/Treatment	Phase
Carcinoid Tumor	Other: Medical data collection

Detailed Description

The objective of this study is to evaluate the feasibility and therapeutic method of endoscopic treatment of bronchial carcinoid tumors.

Study Design

• Study Type: Observational
• Actual Enrollment: 70 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Feasibility and Therapeutic Method of Endoscopic Treatment of Bronchial Carcinoid Tumors: 22 Years Experience of Saint-Etienne
• Actual Study Start Date: Nov 1, 1995
• Actual Primary Completion Date: Dec 1, 2017
• Actual Study Completion Date: Dec 1, 2017

Arms and Interventions

Arm	Intervention/Treatment
endoscopic treatment Patient with endoscopic treatment will be included. Some medical data collection by medical record will be collected.	Other: Medical data collection; Medical data collection by medical record will be collected: demographics data, medical history, clinical symptoms, smoking, type of endoscopic method, complete treatment or not, type of surgeries if yes, anatomopathology of the injury and recurrence if yes

Outcome Measures

Primary Outcome Measures

1. Complete endoscopic treatment [Month 1]

   patients who have a complete endoscopic treatment

Secondary Outcome Measures

1. Type of endoscopic method used [Month 1]

   Analysis type of endoscopic method used.

2. Tumor localization [Month 1]

   Analysis the tumor localization.

3. Deadline before recurrence [10 years]

   Analysis the deadline before recurrence of the tumor.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Patients treated by endoscopic approach for a carcinoid tumor at the University Hospital Centre of Saint-Etienne between November 1995 to December 2017.

Exclusion Criteria:

• Patients treated for a recurrence of carcinoid tumor.

• Patients with metastatic disease.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHU de Saint-Etienne	Saint-Étienne		France	42055

Sponsors and Collaborators

• Centre Hospitalier Universitaire de Saint Etienne

Investigators

• Principal Investigator: Jean-Michel VERGNON, PhD, CHU SAINT-ETIENNE

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Centre Hospitalier Universitaire de Saint Etienne
• ClinicalTrials.gov Identifier: NCT03723499
• Other Study ID Numbers: IRBN812018/CHUSTE
• First Posted: Oct 29, 2018
• Last Update Posted: Oct 29, 2018
• Last Verified: Oct 1, 2018

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Centre Hospitalier Universitaire de Saint Etienne: Carcinoid tumors; Endoscopic treatment; Recurrence
• Additional relevant MeSH terms: Carcinoid Tumor

Study Results

No Results Posted as of Oct 29, 2018